Group items tagged

The Royal Pharmaceutical Society (RPS) has re-elected Andrew Carruthers as chair of RPS Scotland Pharmacy Board. Andrew is a Medicines Governance pharmacist within NHS Greater Glasgow and Clyde, where he has a clinical commitment to Care of the Elderly. Prior to becoming a pharmacist, he studied Pharmacology at the University of Glasgow, and maintains a keen interest in pharmacokinetics and research. In his address for the position, he said: "In my second term I want to continue to support and drive the introduction of RPS Ambassadors and the creation of an online RPS community." "As a previous RPS local coordinator, I've seen first-hand that RPS Local events are a great forum to formally support the training and development of local pharmacists. With input from our members and RPS staff we could share learning, inspire, and enable development, and build a supportive online community for the profession." He was the RPS Local Co-ordinator for Greater Glasgow and Clyde for 3 years, then he co-opted on to the Scottish Pharmacy Board (SPB) in 2018 and have been an active and effective member of the board. He was re-elected to the board in 2021 and he stood and was elected as Chair.

RPS Scotland has named Fiona McIntyre as its new Policy and Practice Lead. With a background in hospital pharmacy, McIntyre will be responsible for policy development and professional support at RPS Scotland, and is set to assume her new role in early October. McIntyre will assume a leadership role for specific projects across Great Britain, collaborating with the Policy and Practice Leads in England and Wales, RPS Scotland said in a statement. Her responsibilities include representing pharmacists in working groups and meetings, engaging with pharmacists and pharmacy organisations, and supporting the RPS Director for Scotland. "During my career in NHS Scotland, I have advocated for pharmacy teams whenever possible," said McIntyre. "I am passionate about the profession's role in the safe and effective use of medicines, and I'm privileged to join the RPS. I look forward to promoting pharmacy in Scotland and helping our profession reach its full potential." "I'm pleased that Fiona will be joining the RPS Scotland team as our policy lead," said Laura Wilson, Director for RPS Scotland. "Fiona's experience will be invaluable to the role, and the whole team looks forward to her starting with us in October."

The Royal Pharmaceutical Society (RPS) has appointed James Davies as Director of England. Davies will be joining RPS in January 2023 to drive professional leadership for the pharmacy profession in England, working with and for RPS members. He'll lead on national policy development, professional advocacy and member engagement across England, in partnership with the English Pharmacy Board. Davies said: "It's a privilege to take up this position within the RPS, the professional home of pharmacy. I have been a member of the RPS throughout my pharmacy career, and that has helped me to continually drive excellence in pharmacy practice. I'm excited about delivering the current RPS strategy to ensure that pharmacy is, and continues to be, at the forefront of healthcare. I'm eager to work as part of the team and with the Board, leading and developing opportunities for the profession that improve the lives of patients and the public.

The Royal Pharmaceutical Society (RPS) has appointed Laura Wilson as Director for Scotland commencing 23rd January 2023. Laura, is currently Policy and Practice Lead for RPS in Scotland. She is accountable for bringing national RPS policy to life for members in Scotland, while contributing to the GB wide professional leadership agenda. She will work closely with the Scottish Pharmacy Board, senior NHS officials and other key stakeholders across the breadth of the pharmacy profession and beyond to ensure pharmacy is on the forefront of healthcare in Scotland. She joins the existing team of RPS Country Directors, which includes Elen Jones, Director for Wales and James Davies, Director for England and will report directly to the Chief Executive. Laura Wilson said: "I am delighted to be appointed Director for Scotland having worked as part of the RPS Scotland team as the policy and practice lead. It will be an honour to continue the fantastic work started by former Director Clare Morrison to bring Pharmacy 2030, our vision for pharmacy in Scotland in the future, to life and supporting pharmacy teams to deliver person centred care.

The Pharmacists' Defence Association (PDA) said it has supported the application of the Royal Pharmaceutical Society (RPS) to rejoin the International Pharmaceutical Federation (FIP), the global body representing the interests of pharmacy. Under FIP rules, if a new application from an additional organisation from the same country applies to join, the existing members in that country are consulted about that decision and are asked for their approval before FIP council members determine if the application is accepted. The PDA joined FIP earlier this year, and RPS, which has decided not to renew FIP membership at the end of last year, has now submitted a fresh application to join. RPS decision to leave, taken after a vote, has invited much criticism. The organisation, a founding member, had attributed high membership fees and associated costs for leaving FIP While the PDA has confirmed that it would not oppose the membership application of the RPS, it has asked FIP to find a suitable method to ascertain a transparent declaration of membership numbers from the RPS in the event of FIP Council deciding to admit RPS.

The Royal Pharmaceutical Society (RPS) has announced the results of the elections to vacant positions on the RPS Scottish and English Country Boards that took place at the meeting on June 18. The Scottish Pharmacy Board elected Jonathan Burton, FRPharmS, as their new Chair and Audrey Thompson to the RPS Assembly, the organisation's governing body. Jonathan is a community pharmacist and an independent prescriber affiliated with the Right Medicine Pharmacy group in Stirling. He has played an integral role in the inception, development and delivery of Pharmacy First services in Scotland. He is an RPS Fellow and received an MBE in 2018 for services to healthcare. Jonathan is also the recipient of the 2023 RPS Charter Award. He previously served as Chair of the Scottish Pharmacy Board from 2019 to 2021. "Serving as Chair is a great privilege," said Jonathan while expressing his delight at being elected as the Chair of the Scottish Pharmacy Board.

Kami Dari Agen Xamthone Plus Purbalingga Datang Di Daerah Purwokerto Untuk Memudahkan Warga Purwokerto Mendapatkan Obat Herbal Xamthone Plus.Anda Cukup SMS Ke Kami Maka Pesanan Langsung Kami Kirim,Berhubung Kami Belum Punya Agen Resmi Agen xamthone plus Purwokerto Maka Kami Ingin Mengajak Warga Kususnya Wilayah Purwokerto Untuk menjadi Agen Xamthone Plus Purwokerto Sebagai Perwakilan Agen Xamthone plua Purbalinga/agenxamthone-plus.com.Kami Akan Bantu Dalam Pemsarannya Melalui WEB Kami www.agenxamthone-plus.com. Sarat Untuk Menjadi Agen Xamthone Plus Purwokerto Hanya Beli Sekali Rp 1.425.000, Mendapatkan 7 Botol Xamthone Dan Anda Akan Mendapatkan Kartu Member Agar Pembelanjaan Berikutnya Mendapatkan Diskon Yaitu Untuk Belanja 6 Botol Hanya Rp 1.000.000. #SEGERALAH BERGABUNG KARNA INI KESEMPATAN EMAS JANGAN DI SIA- SIAKAN KAMI YAKIN ANDA JUGA BISA SUKSES!!!!!!! Berikut Alamat Yang Bisa Di Hubungi: * NAMA ; HAMDI * ALAMAT : .DESA METENGGENG RT.17 RW 09-KEC BOJONGSARI-KAB PURBALINGGA 53362 *NO PHONE : 085842519669 / 081385212084 Apabila Alamat Yang Di Tatas Tidak Bisa Di Hubungi Atau Lagi Kehabisan Stoke Maka Barang Kami Kirim Dari Pusat (Jakarta ).Anda Jangan Kawatir Dengan Agen Kami Karna Kami Melayani Pengiriman Pesanan /Barang Dulu Setelah Sampai Baru Transfer Pembayaran. Berikut Alamat Agen Pusat Kami *NAMA : DIAN MAULANA *ALAMAT :Jl Benda Timur 6 E66/ 16 pamulang Permai-2,Kota tangerang selatan *NO PHONE 021-91894743 / 081385212084 *Pembelian 1 botol xamthone plus Rp. 230.000 *Pembelian 2,3,4,&5 Harga Nego Table *Pembelian 6 botol xamthone plus Rp. 1.200,000,- Berikut Cara Pemesanan DXP : Nama : Alamat Pengiriman: Jumlah Pesanan : No. Hp / Telpon : Contoh DXP 3 Xamthone : RIYAN M : JL BENDA BARAT 6 EE66/16 PAMULANG PERMAI 2 TANGSEL. Untuk pemesanan Satu Botol akan di kenakan ongkos kirim Rp 20.000.Dan Untuk Pembelian 2Botol Ke atas Bebas ongkos kirim ( Untuk Jakarta

In partnership with Oxford University Press, the Royal Pharmaceutical Society (RPS) has launched the 'RPS Pharmacy and Pharmacology' reports. RPS Pharmacy and Pharmacology Reports is a new, fully open access journal and the sister journal to Journal of Pharmacy & Pharmacology. The journal is edited by Professor Dennis Douroumis, professor in Pharmaceutical Technology and Process Engineering at the University of Greenwich. RPS said: "The journal aims to create a truly interdisciplinary forum for members of the pharmacy, pharmacology, chemistry, biochemistry, physiology, and microbiology communities alike to come together to develop life-changing medicines of the future. The journal prioritises scientifically sound results from pharmacy and pharmacology researchers across the world." The journal operates a rapid review and publication process to ensure impactful research is disseminated as quickly as possible. All RPS members are eligible to receive a 20 per cent discount on the article processing charge.

The Royal Pharmaceutical Society (RPS) has appointed Dr Anthony Cox from the University of Birmingham as the new chair of its Education and Standards Committee. Anthony is Head of the School of Pharmacy and a Reader in Clinical Pharmacy and Drug Safety. He has previously been a member of the English Pharmacy Board and is a Fellow of the RPS. The Education and Standards Committee provides expert advice and makes recommendations to the RPS Education and Professional Development directorate, reporting directly to the RPS Assembly. Dr Anthony Cox said: "I'm looking forward to working with the committee during this vitally important time for the education of the profession at all levels, and delighted to support the RPS in continuing to develop and deliver its important role in defining and assuring post-registration standards of pharmacy practice."

The Royal Pharmaceutical Society (RPS) has re-joined the International Pharmaceutical Federation (FIP) after reflecting its commitment to international collaboration and the advancement of the pharmacy profession. RPS President Professor Claire Anderson said: "Members told us they wanted to see us re-join FIP to further our commitment to international partnerships which support education and advocacy to develop and progress the pharmacy profession.". "We fully recognise the importance of international collaboration and the sharing of knowledge and best practice with our peers across the world. "FIP are refocusing their membership offer and we're delighted to work with them on opportunities for professional development and increased visibility and recognition for the pharmacy profession." Paul Bennett, RPS CEO said: "Now that we have re-joined, our teams across RPS look forward to reinvigorating the close collaboration we have previously enjoyed with our colleagues both within FIP itself, and across the breadth of FIP Member organisations to further our vision and mission".

The Royal Pharmaceutical Society is set to cease all its remaining financial investments in fossil fuels latest by the end of 2022. The decision taken today (November 17) at the RPS Assemble, is part of the organisation's "continued drive to become an environmentally responsible organisation." Calling it a significant move, RPS president Claire Anderson said: "RPS will divest from fossil fuels as soon as possible. "RPS will instruct its investment managers immediately to ensure that we will be completely disinvested by the end of 2022 and hopefully sooner." Environment and human wellbeing have always been a core consideration of RPS investment, however it was not enough to offset the negative impacts of climate change, the organisation said.

As part of its inclusion and diversity strategy, the Royal Pharmaceutical Society (RPS) has launched a campaign to challenge barriers to working in pharmacy for those with disabilities. A profession-wide survey on the subject conducted by the RPS, identified disability as the biggest barrier to working in pharmacy, highlighting the area of work to support pharmacists. The campaign will focus on reducing barriers to enter the profession, developing more accessible working environments and encouraging employers to collect data on disability in the workplace. The campaign, based on inputs from the RPS Ability Group volunteers with visible and non-visible disabilities, will run until the end of March. Following recommendation of the RPS Ability Group, RPS has written to the General Pharmaceutical Council (GPhC) the Higher Education Occupational Practitioners (HEOPS) to update the guidance on standards of medical fitness for pharmacy students.

The Pharmacists' Defence Association (PDA) has advised its member to check their understanding of what activities can legitimately take place when no RP is signed in at the pharmacy or the absence provisions are used. The advisory to its member was followed after noticing a considerable talk on social media about compliance with the Responsible Pharmacist (RP) regulations which also included unauthorised activity occurring when no RP is signed in. "There have been comments made that some pharmacists and pharmacy team members may fear repercussions from challenging or whistle-blowing about such behaviour," PDA said. "To assist members with the interpretation of the RP regulations, the PDA has made available a legal briefing note about the RP regulations produced by a specialist pharmacy regulation law firm." It further added: "Non-compliance with the regulations by pharmacy teams should be reported to the pharmacy superintendent."

The Royal Pharmaceutical Society (RPS) Wales and the Association of the British Pharmaceutical Industry (ABPI) co-hosted a drop-in session to inform members of the Senedd (MSs) about the action taken by pharmacists to make medicines use more sustainable. At a 'drop-in' session the ABPI, RPS members and staff had the opportunity to speak to a number of MSs from all political parties. "With medicines accounting for around 25 per cent of the NHS carbon emissions, conversations were based around the key recommendations to reverse this from the RPS' policies on sustainability," said RPS. The three key themes emphasised in all discussions were- the need to educate the public and change behaviours to avoid stockpiling medicines; How the clinical skills of prescribing pharmacists can be used for appropriate de-prescribing and switching patients to low carbon options; and importance of tackling waste. RPS Wales Director Elen Jones said: "It was fantastic to see how interested and engaged the politicians were around these important issues. By the end of our conversations, they all clearly understood and supported the importance of pharmacy leadership in this area, as well as the need for the link between climate change and medicines to be better understood by patients.

The Royal Pharmaceutical Society (RPS) Scotland has launched an online pharmacy best practice hub to showcase the best practices adopted by pharmacy teams in Scotland. The brand new pharmacy best practice hub, hosted on the RPS Scotland website, went live on Thursday (August 11). RPS Scotland said: "Pharmacy teams across Scotland are undertaking fantastic work right now, in a variety of settings including community, hospital and general practice pharmacy as well as specialist settings. Many of these examples demonstrate the very best in pharmacy practice, which is supporting the profession to move further towards RPS Scotland's professional vision for the future of pharmacy, Pharmacy 2030." RPS wants to celebrate and share these examples with healthcare professionals, government, politicians, the public and potential pharmacy students to inspire people into the profession. It also provides a fantastic opportunity for pharmacy teams to share their practice with each other across the country.

The Royal Pharmaceutical Society (RPS) in collaboration with Health Education England's Centre for Advancing Practice and the Centre for Pharmacy Post Graduate Education (CPPE) will provide a pharmacy-specific professional development pathway for advanced pharmacist practice. Successful completion of the pathway, assured through the RPS Core Advanced Pharmacist Curriculum assessment, will result in pharmacists being recognised by RPS as an advanced pharmacist, along with the awarding of HEE's Centre for Advancing Practice's 'Advanced' digital badge, demonstrating the quality assurance of their advanced practice preparation to patients, families, carers, and other healthcare professionals. The first participants in a fully funded, supported e-portfolio pathway to recognise advanced pharmacist practice in England will get underway in March 2023 This new programme is an important step in creating a clear postgraduate career structure for pharmacists in England. The innovative approach provides funding from HEE's Centre for Advancing Practice in 2023-24 for 300 pharmacists in England who are near to, or already practicing at, an advanced level, to enable them to receive supervision and support in building their RPS Core Advanced e-Portfolio from CPPE's pharmacy education supervisors.

In September, the Royal Pharmaceutical Society (RPS), the professional leadership body for pharmacists and pharmaceutical scientists in Great Britain, announced its proposal to transition into a Royal College. This significant step, which came following an 18-month independent review of the RPS constitution and governance, aims to strengthen the RPS's leadership role, with the ultimate goal of delivering greater benefits to patients and the public. In an exclusive interview with Pharmacy Business, Tase Oputu, chair of the RPS English Pharmacy Board, discusses the key reasons behind the proposed changes, the potential impact on pharmacists and patients, and her personal journey as the first Black Chair of the RPS Board. Benefits for pharmacists and patients When asked how this transition would benefit pharmacists and patients, Tase says, "I'm excited about RPS' proposals for change. In my view, becoming a Royal College would elevate the status of the profession and strengthen our ability to raise the profile of pharmacy, advocate for change and advance the safe and effective use of medicines for the benefit of patients and the public."

A member of the English Pharmacy Board and RPS Assembly, Sharon Isobel Tait Buckle (also known as Sibby) has been elected unopposed as the treasurer of the Royal Pharmaceutical Society (RPS). Sibby takes over the role from Andre Yeung, whose tenure ended in June 2022. Sibby was first elected to the English board in 2012 and is the first woman to hold the post since RPS became the professional leadership body in 2010. She is already part of the Finance and Investment Committee, where RPS budgets, pensions, assets, financial priorities and performance, reserves and investment policies are scrutinised and agreed. Commenting on her new role, Buckle said: "I want to build on the great contribution made by our previous Treasurer. Over the next two years of my tenure I will monitor and challenge our financial performance, our focus on Environmental, Social and Governance factors (ESG), investment strategy and performance and our financial governance.

The Royal Pharmaceutical Society (RPS) has published its new 'Core Advanced Pharmacist Curriculum' to enable professional development towards advanced pharmacist practice. This follows an intensive programme of work undertaken in collaboration with a wide range of UK stakeholders, the society said today (June 27) in a statement. The Curriculum will equip pharmacists with advanced leadership, education, and research capabilities which are essential to support, lead and advance the profession through transformative change so it continues to meet evolving patient and service requirements. The RPS Core Advanced Curriculum provides the blueprint to develop such individuals by articulating a UK entry-level standard to advanced pharmacist practice, relevant to all patient-focussed pharmacist roles and aligned to multi-professional definitions of advanced practice. This curriculum completes the core RPS post-registration curricula, creating a seamless post-registration professional development continuum modelled around five common domains- Person-centred care and collaboration; Professional practice; Leadership and management; Education; and Research.

The Royal Pharmaceutical Society (RPS) has appointed Neville Carter as its new chief education and membership officer. Neville joins RPS from the Royal Society of Medicine (RSM) where he is currently director of engagement, leading a team of over 60 and responsible for creating a combined directorate accountable for education, membership, philanthropy, and business development. He has, in particular, led on the development of a digital education strategy and launched professional development training programmes for members. Prior to joining the RSM, Neville worked as director of product and sales at the British Medical Association with responsibility for membership growth, supporting corporate transformation and developing and managing member benefits and relationships with third-party providers to support revenue growth. He also has senior manager experience at the RAC and at British Airways. Commenting on the appointment, Paul Bennett, RPS CEO, said: "I'm delighted that Neville will be joining our Executive team. He brings a wealth of relevant experience and this, in combination with a strong existing education and membership team at RPS and a clear ambition to strengthen the relevant functions further, will enable the organisation to deliver a dynamic offering for our members.